practical considerations for immunotherapy in stage 3 nsclc
Published 6 years ago • 340 plays • Length 9:57Download video MP4
Download video MP3
Similar videos
-
1:38
practical considerations for durvalumab in stage 3 nsclc
-
2:32
practical considerations for adjuvant vs. neoadjuvant immunotherapy in nsclc
-
7:44
immunotherapy in stage iii nsclc
-
6:50
implications for using durvalumab in stage 3 nsclc
-
1:13
immunotherapy in stage iii nsclc metastatic disease
-
2:34
dr. langer on practice-changing pacific data in stage iii nsclc
-
1:00:44
practical application of recent clinical data for immunotherapy in nsclc
-
5:30
resolving practice barriers to consolidative immunotherapy in stage iii nsclc
-
7:44
immunotherapy in stage iii nsclc
-
6:20
immunotherapy in stage iii nsclc: practice-changing results of pacific trial (bmic-006)
-
55:59
leveraging immunotherapy and egfr targeted treatment in unresectable stage iii nsclc
-
2:10
unmet needs and role of immunotherapy in stage 3 nsclc
-
1:02:36
practice changes for use of immunotherapy in nsclc
-
3:46
nsclc stage iii unmet needs and practical advice
-
1:28
dr. donington on neoadjuvant immunotherapy in lung cancer
-
![[lung]the role of durvalumab in patients with stage 3 lung cancer in a real hospital](https://i.ytimg.com/vi/EwpYIgllxqY/mqdefault.jpg)
3:53
[lung]the role of durvalumab in patients with stage 3 lung cancer in a real hospital
-
59:24
marking new milestones with immunotherapy in locally advanced and early lung cancer
-
2:20
dr. antonia on investigational immunotherapy combinations in stage iii nsclc
-
59:37
marking new milestones with immunotherapy in locally advanced and early lung cancer